VCAM-1 activates phosphatidylinositol 3-kinase and induces p120Cbl phosphorylation in human airway smooth muscle cells

被引:30
|
作者
Lazaar, AL
Krymskaya, VP
Das, SKP
机构
[1] Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA
[2] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 166卷 / 01期
关键词
D O I
10.4049/jimmunol.166.1.155
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
VCAM-1 is a member of the Ig superfamily of receptors the expression of which is up-regulated on human airway smooth muscle (ASM) cells following stimulation with inflammatory mediators. The function of these receptors in adhesion is well known, but there is growing recognition that they also possess "outside-in" signaling functions, such as cytoskeletal reorganization, calcium mobilization, and cytokine release. The present study examined the activation of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase (PUK) in ASM cells following VCAM-1 engagement, VCAM-1 ligation activated extracellular signal-regulated kinase 2 and resulted in increased expression of cyclin D1, yet there was neither p27(kip1) degradation nor an increase in smooth muscle cell DNA synthesis. VCAM-1 ligation, however, augmented the proliferative response to submitogenic concentrations of epidermal growth factor, VCAM-1 engagement also stimulated a rapid increase in PI3K activity. This was associated with phosphorylation of the adapter protein p120(Cbl) and an increase in Cbl-associated PI3K activity. These studies suggest that VCAM-1 is linked to multiple signaling pathways in human ASM cells and may function to augment growth factor-induced responses.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 50 条
  • [1] Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase
    Suresh K Jain
    Wallace Y Langdon
    Lyuba Varticovski
    Oncogene, 1997, 14 : 2217 - 2228
  • [2] Association of activated phosphatidylinositol 3-kinase with p120cbl in antigen receptor-ligated B cells
    1600, American Society for Biochemistry and Molecular Biology Inc., Bethesda, United States (270):
  • [3] EGF activates ErbB-2 and stimulates phosphatidylinositol 3-kinase in human airway smooth muscle cells
    Krymskaya, VP
    Hoffman, R
    Eszterhas, A
    Kane, S
    Ciocca, V
    Panettieri, RA
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 276 (02) : L246 - L255
  • [4] Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells
    Saward, L
    Zahradka, P
    CIRCULATION RESEARCH, 1997, 81 (02) : 249 - 257
  • [5] Fc receptor-mediated platelet activation is dependent on phosphatidylinositol 3-kinase activation and involves p120cbl
    Saci, A
    Pain, S
    Rendu, F
    Bachelot-Loza, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) : 1898 - 1904
  • [6] Crosslinking VCAM-1 on human airway smooth muscle activates ERK2 and p70S6 kinase.
    Lazaar, AL
    Krymskaya, V
    Panettieri, RA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A721 - A721
  • [7] TGF-β1 modulates EGF-stimulated phosphatidylinositol 3-kinase activity in human airway smooth muscle cells
    Krymskaya, VP
    Hoffman, R
    Eszterhas, A
    Ciocca, V
    Panettieri, RA
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 273 (06) : L1220 - L1227
  • [8] Tyrosine phosphorylation of p120(cbl) in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase
    Jain, SK
    Langdon, WY
    Varticovski, L
    ONCOGENE, 1997, 14 (18) : 2217 - 2228
  • [9] Insulin activates a p21-activated kinase in muscle cells via phosphatidylinositol 3-kinase
    Tsakiridis, T
    Taha, C
    Grinstein, S
    Klip, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (33) : 19664 - 19667
  • [10] Targeting the phosphatidylinositol 3-kinase pathway in airway smooth muscle - Rationale and promise
    Krymskaya, Vera P.
    BIODRUGS, 2007, 21 (02) : 85 - 95